Adial Pharmaceuticals Shares Drop After Announcing 1-for-25 Reverse Split
Adial Pharmaceuticals Inc. reported a 1-for-25 reverse stock split that will take effect February 5, 2026, and said the move is intended to restore compliance with Nasdaq’s $1.00 minimum bid price rule. The announcement coincided with a 19.9% decline in the company's stock in after-hours trading on Tuesday.